Hazer Group (ASX:HZR) has completed its commercial demonstration plant and reactor test program, marking a step in the company's technological advancements. The achievement is expected to ...

Recce Pharmaceuticals (ASX:RCE) has dosed all 30 patients in its Phase 2 clinical trial assessing the efficacy of RECCE 327 topical gel for the treatment of acute bacterial skin and skin structure ...

Novonix (ASX:NVX) has entered into an exclusive licensing agreement with long-time technology partner, Harper International Corporation. The agreement grants Novonix the rights to Harper's continuous, ...

Decentralised finance (DeFi) advocates believe artificial intelligence (AI) could be a game-changer in combating cybercrime and enhancing platform security. According to Peckshield’s Annual Crypto ...

The Bank of England plans to launch the Digital Pound Lab in 2025 as part of its Central Bank Digital Currency (CBDC) design phase. Collaboration with HM Treasury and global experts focuses on privacy ...

In a strategic move reshaping its vaccine operations, WuXi Biologics announced on Monday that its subsidiary, WuXi Vaccines Ireland, has entered into an agreement with Merck & Co. (NYSE:MRK) to sell ...

British pharmaceutical giant GSK (NYSE:GSK) is reportedly in advanced talks to acquire IDRx, a privately-held biotechnology company focused on developing treatments for a rare type of tumor. According ...

Phio Pharmaceuticals Corp. (NASDAQ:PHIO), a clinical-stage biotechnology company, has announced positive results from its ongoing Phase 1b clinical study evaluating the use of its INTASYL® siRNA gene ...

Eliza Labs, the developer behind ai16z (CRYPTO:AI16Z), has released a white paper detailing its vision for Web3-native artificial intelligence agents. The document outlines the capabilities of Eliza, ...

Japanese investment firm Metaplanet is aiming to expand its Bitcoin (CRYPTO:BTC) holdings to 10,000 BTC by the end of 2025, according to CEO Simon Gerovich. In a recent announcement, Gerovich detailed ...

Emerging cryptocurrency exchange-traded funds (ETFs) for Solana (CRYPTO:SOL) and XRP (CRYPTO:XRP) may attract substantial investments if approved, according to a recent report by JPMorgan. The ...

Shares of Charles River Laboratories (NYSE:CRL) dropped 11.1% to $169.01 in premarket trading following the company’s revised revenue forecast for 2025. The contract research firm announced that it ...